BioArctic AB will publish its second quarter financial report for April to June 2026 on August 26, 2026, at 8:00 a.m. CEST. The company will hold a webcast at 9:30 a.m. CEST the same day, where CEO Gunilla Osswald and CFO Anders Martin-Löf will present the results and answer questions. Investors and media can join the webcast or teleconference to learn about the company's performance and outlook. BioArctic is known for its innovative treatments for neurodegenerative diseases, including the Alzheimer's drug Leqembi®.
The documentary 'NURSE: Empathy Heals' premiered on October 21 in Nashville, showcasing personal stories of nurses and the critical role of empathy in healthcare. It highlights the emotional challenges nurses face, especially during crises like the C...
Oxford Square Capital Corp. announced it will hold a conference call on October 30, 2026, at 9:00 AM Eastern time to discuss its third quarter 2026 earnings. Investors can join the call via a toll-free number, and a recorded replay will be available ...
Del Valle ISD Education Foundation in Austin, Texas, received the F1 Allwyn Global Community Award and a €100,000 grant from Allwyn during the 2026 Formula 1 United States Grand Prix. The funding supports the Fast Track initiative, which provides sch...
The Del Valle ISD Education Foundation in Austin, Texas, received the F1 Allwyn Global Community Award and a €100,000 grant from Allwyn to fund its 'Fast Track' initiative. This program aims to support 12,000 students by providing scholarships, teach...
The Del Valle ISD Education Foundation in Austin received the F1® Allwyn Global Community Award, securing a €100,000 grant from Allwyn to fund its Fast Track program. This initiative supports 12,000 students in disadvantaged areas by providing STEM s...
